Elizabeth M Jaffee Selected Research

DNA (Deoxyribonucleic Acid)

10/2023	Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction.
1/2021	A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint.
7/2011	Increased expression of DNA repair genes in invasive human pancreatic cancer cells.
7/2009	SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
4/2009	Genetic mutations associated with cigarette smoking in pancreatic cancer.
9/2008	Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth M Jaffee Research Topics

Disease

152	Neoplasms (Cancer) 05/2024 - 01/2003
50	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 08/2004
42	Adenocarcinoma 02/2024 - 12/2007
16	Neoplasm Metastasis (Metastasis) 05/2024 - 04/2011
16	Breast Neoplasms (Breast Cancer) 02/2024 - 09/2003
9	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 12/2007
8	Melanoma (Melanoma, Malignant) 01/2023 - 01/2013
7	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2017
4	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2014
3	Inflammation (Inflammations) 04/2024 - 07/2013
3	Triple Negative Breast Neoplasms 02/2024 - 01/2020
3	Bites and Stings (Sting) 01/2021 - 01/2017
3	Hypersensitivity (Allergy) 10/2014 - 02/2005
2	Tertiary Lymphoid Structures 10/2023 - 07/2014
2	COVID-19 01/2022 - 01/2021
2	Margins of Excision 01/2021 - 01/2018
2	Carcinogenesis 01/2020 - 04/2015
2	Microsatellite Instability 10/2019 - 11/2017
2	Carcinoma (Carcinomatosis) 04/2015 - 08/2003
2	Barrett Esophagus (Barrett's Esophagus) 11/2008 - 01/2008
2	Esophageal Neoplasms (Esophageal Cancer) 11/2008 - 01/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2005 - 02/2005
1	Thyroid Neoplasms (Thyroid Cancer) 10/2023
1	Turcot syndrome 12/2022
1	Neoplasm Micrometastasis 01/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

58	VaccinesIBA 04/2024 - 01/2003
27	AntigensIBA 02/2024 - 09/2003
26	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 08/2003
23	Cancer VaccinesIBA 04/2024 - 07/2003
17	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2014
15	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2013
14	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 01/2003
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2003
13	AntibodiesIBA 11/2022 - 04/2011
11	MesothelinIBA 02/2024 - 08/2004
9	IpilimumabIBA 02/2024 - 07/2013
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2005
8	RNA (Ribonucleic Acid)IBA 04/2024 - 10/2018
8	NivolumabIBA 02/2024 - 01/2015
8	CytokinesIBA 01/2020 - 01/2005
7	Monoclonal AntibodiesIBA 11/2022 - 08/2003
7	Peptides (Polypeptides)IBA 01/2021 - 04/2003
6	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 09/2008
6	Annexin A2 (Annexin II)IBA 01/2019 - 04/2011
5	EpitopesIBA 01/2015 - 04/2003
4	pembrolizumabIBA 04/2024 - 01/2015
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2012
4	entinostat (MS 275)IBA 02/2024 - 12/2018
4	Trastuzumab (Herceptin)FDA Link 10/2014 - 08/2003
3	Small Cytoplasmic RNAIBA 04/2024 - 10/2019
3	Programmed Cell Death 1 ReceptorIBA 04/2024 - 01/2020
3	Histone Deacetylase InhibitorsIBA 01/2022 - 12/2018
3	InterferonsIBA 01/2021 - 01/2015
3	LigandsIBA 01/2020 - 01/2015
3	Gemcitabine FDA Link 11/2017 - 07/2011
2	Chimeric Antigen ReceptorsIBA 05/2024 - 07/2013
2	Hormones (Hormone)IBA 02/2024 - 09/2003
2	Semaphorins (Semaphorin)IBA 10/2023 - 08/2015
2	cabozantinibIBA 01/2023 - 01/2023
2	Drug CombinationsIBA 11/2022 - 04/2017
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	atezolizumabIBA 10/2021 - 01/2021
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	Metformin (Glucophage)FDA LinkGeneric 05/2020 - 04/2015
2	ChemokinesIBA 01/2020 - 01/2018
2	AnnexinsIBA 01/2019 - 04/2011
2	Mitogen-Activated Protein KinasesIBA 01/2019 - 09/2012
2	amatuximabIBA 12/2016 - 12/2007
2	GVAX vaccineIBA 12/2015 - 01/2015
2	Oncogene Proteins (Oncogene Protein)IBA 04/2015 - 09/2007
2	sipuleucel-T (APC8015)FDA Link 01/2015 - 07/2013
1	Epidermal Growth Factor (EGF)IBA 05/2024
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 04/2024
1	Growth Differentiation Factor 15IBA 01/2024
1	plexinIBA 10/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2023
1	Protein Subunit VaccinesIBA 10/2023
1	Interleukin-8 (Interleukin 8)IBA 11/2022
1	Bispecific AntibodiesIBA 11/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Immunomodulating AgentsIBA 12/2021
1	OvalbuminIBA 12/2021
1	Immunoglobulin E (IgE)IBA 12/2021
1	cobimetinibIBA 10/2021

Therapy/Procedure

68	Immunotherapy 11/2023 - 09/2003
65	Therapeutics 05/2024 - 07/2003
15	Drug Therapy (Chemotherapy) 01/2022 - 09/2003
7	Radiotherapy 02/2024 - 10/2010
6	Precision Medicine 01/2023 - 11/2017
2	Intravenous Injections 02/2019 - 02/2012
2	Aftercare (After-Treatment) 01/2015 - 01/2015
1	Radioimmunotherapy 02/2024
1	Organ Transplantation 12/2022
1	Neoadjuvant Therapy 11/2022
1	Molecular Targeted Therapy 01/2022
1	Immunomodulation 10/2021